Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation |
| |
Authors: | Lietman Steven A Kalinchinko Natasha Deng Xichao Kohanski Ronald Levine Michael A |
| |
Institution: | The Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio 44195, USA. lietmas@ccf.org |
| |
Abstract: | We describe a novel missense mutation (Aspartic acid to Asparagine, p.D419N (g.1371G>A, c.1255G>A) within exon 9 of SH3BP2 in a patient with cherubism, an autosomal dominant syndrome characterized by excessive osteoclastic bone resorption of the jaw. Two siblings and the father were carriers but lacked phenotypic features. Transient expression of p.D419N (c.1255G>A), as well as three previously described exon 9 mutations from cherubism patients (p.R415Q (c.1244G>A), p.D420E (c.1259G>A), and p.P418R (c.1253C>G)) increased activity of NFAT (nuclear factor of activated T-cells), an osteoclastogenic mediator, indicating that cherubism results from gain of function mutations in SH3BP2. |
| |
Keywords: | SH3BP2 cherubism NFAT osteoclastogenesis giant cell tumor bone bone resorption |
本文献已被 PubMed 等数据库收录! |
|